From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Celadon Pharmaceuticals: does anyone out there other than Sarah McLeod believe the forecasts?

By Tom Winnifrith, the Sheriff of AIM | Wednesday 19 June 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


In early May I flagged up HERE that the statements made by Celadon Pharmaceuticals (CEL) about sales contracts ahead of it getting away bailout placings were, at best wildly optimistic and, at worst, downright misleading. Since then, the shares have, as I have often predicted headed only one way and that is South. I now ask the question does anyone other than FemiNazi PR Sarah McLeod actually believe its current forecasts?
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Wednesday »

Tom

Are you coming to Sharestock on September 7?

 

VANL

Van Elle Holdings – a Buy?

Thursday »

CCT

Character Group – a Buy?

 

ING

Ingenta – now a Buy again?

 

Clown

Which PR genius wrote this?

 

HAT

H&T Group – now again a Buy

Time left: 01:19:37